Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies

     Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies

North America's First Sysmex XN-9000 goes live at Mercy Medical Center,
improving the speed and accuracy of Hemoglobin A1c tests, treatment decisions

PR Newswire

CANTON, Ohio, June 19, 2013

CANTON, Ohio, June 19, 2013 /PRNewswire/ --Mercy Medical Center recently
implemented advanced clinical laboratory diagnostics technology for conducting
on-demand, Hemoglobin A[1c] (HbA[1c]) diabetes testing, as well as analysis of
important red blood cell, white blood cell and platelet counts. The new system
enables the hospital to provide faster, more accurate lab results for
physicians and their patients, which can improve treatment decisions. 


As North America's first installation of its kind, the Sysmex Lavender Top
Management® ^ system, designed and manufactured by Bio-Rad Laboratories, Inc.
(NYSE: BIO and BIOb) and Sysmex America, builds on Mercy's Sysmex
XN-9000™system and further optimizes lab workflow, staffing and space.

Mary Ann Burich-Boccia, administrative director of Mercy Laboratory Services,
believes upgrading and standardizing the lab with the XN-9000 Lavender Top
Management configuration means the hospital can continue to stay ahead of
testing complexities and provide quality HbA[1c] testing and results on a 24/7

"This powerful new platform will greatly benefit patients in our community,
many of whom suffer from diabetes, and it will contribute to positive patient
outcomes," she says. "Our previous platform was the original Lavender Top
Management, and we were able to achieve all our expected productivity gains.
The XN-9000 allows us to continue to improve even further."

New System Incorporates Latest in Automation Technology

The XN-9000, a scalable, configurable automation system, integrates multiple
XN modules, including the Sysmex RU-20™ concentrated reagent dilution unit;
sample sorting and archiving provided by the PVT LabSystems® TS-500; WAM™
decision support software; and Bio-Rad's VARIANT™ II TURBO Link for on-demand
HbA[1c] testing.

With its new system, Mercy will also perform:

  oNRBCs (fluorescent nucleated red blood cell count) with every CBC
    (complete blood count)
  oIG (Immature granulocyte enumeration) with every differential
  oRET-He (Reticulocyte hemoglobin) as a parameter in the reticulocyte
  oIPF (Immature platelet fraction) to aid clinicians in the assessment of

XN-9000 Plays Critical Role in Determining Diabetes Control

The XN-9000 uses HPLC (high-performance liquid chromatography) technology –
the gold standard for HbA[1c] testing – to perform HbA[1c] analysis, which
measures the amount of glucose attached to the hemoglobin in the red blood
cell and estimates blood glucose control during the previous three to four

According to the American Diabetes Association, diabetes affects more than 25
million children and adults in the United States, or 8.3 percent of the
population. It can increase a person's risk for developing serious
complications, including heart disease and stroke, high blood pressure,
blindness, kidney and nervous system diseases. Proper management of the
chronic condition can delay or even prevent the onset of complications,
allowing patients to live healthier, more productive lives.

About Mercy Medical Center

Mercy Medical Center, a ministry of the Sisters of Charity Health System,
operates a 476-bed hospital serving Stark, Carroll, Wayne, Holmes and
Tuscarawas Counties and parts of Southeastern Ohio. It has 620 members on its
Medical Staff and employs 2,500 people. Mercy operates outpatient health
centers in Carroll County, Jackson Township, Lake Township, Louisville, North
Canton, Plain Township and Tuscarawas County. A Catholic hospital, Mercy
Medical Center upholds the mission and philosophy of the Sisters of Charity of
St. Augustine and continues to be responsive to the needs of the community.
For more information, see

About Sysmex America, Inc.

Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe,
Japan), is a world leader in clinical laboratory systemization and solutions,
including clinical diagnostics, automation and information systems. Serving
customers for over 40 years, Sysmex focuses on extending the boundaries of
diagnostic science while providing the management information tools that make
a real difference in clinical and operational results for people worldwide.
For more information about Sysmex, please visit Stay
connected with Sysmex America on Facebook, Twitter, LinkedIn and YouTube.


Contact: Cindy Hickey, Public Relations, 330-430-2767,
Press spacebar to pause and continue. Press esc to stop.